LONGEVITY with Nathalie Niddam #419: A Mind-Blowing Mitochondria Episode— Mito Transplant, Rare Diseases & Biomarkers With Dr. Natalie Yivgi-Ohana
18 snips
Mar 10, 2026 Dr. Natalie Yivgi-Ohana, a mitochondrial scientist and founder of Minovia Therapeutics, explores mitochondria as cellular powerhouses and hormone regulators. She discusses mitochondrial transfer and transplant therapies for rare diseases, scaling donor placenta mitochondria, and developing biomarkers. Conversations also cover metabolic flexibility, aging-related decline, stem cell energy, neuroprotection, and lifestyle supports for mitochondrial health.
AI Snips
Chapters
Transcript
Episode notes
Immune Function Depends On Mitochondrial Capacity
- Immune cell type, function and differentiation depend heavily on mitochondrial content and activity.
- Activated antigen-producing cells and antibody responses need high mitochondrial energy, linking mito-health to immune competence.
Cells Donate Mitochondria Through Nanotube Rescue
- Cells can transfer mitochondria to neighbors through nanotubes when stressed, rescuing function; cancer can hijack this to fuel tumors.
- Mitochondrial transfer is a newly recognized intercellular signaling and rescue mechanism.
Pearson Patients Gained Mobility From Mitochondrial Augment
- Minovia augmented patient blood stem cells with healthy maternal mitochondria to treat Pearson syndrome and saw systemic improvements beyond blood.
- Wheelchair-bound children gained energy, kidney decline stopped, and some regained walking ability after treatment.